Differentiating metabolomic signatures of airway and pulmonary vascular abnormalities in COPD
W. Labaki (Ann Arbor, United States), Y. Wang (Ann Arbor, United States), S. Murray (Ann Arbor, United States), J. Curtis (Ann Arbor, United States), R. Bowler (Denver, United States), C. Pistenmaa (Boston, United States), P. Nardelli (Boston, United States), R. San José Estépar (Boston, United States), R. San José Estépar (Boston, United States), K. Stringer (Ann Arbor, United States), G. Washko (Boston, United States), M. Han (Ann Arbor, United States)
Source: International Congress 2022 – Translational research in COPD and lung cancer
Session: Translational research in COPD and lung cancer
Session type: Thematic Poster
Number: 4252
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Labaki (Ann Arbor, United States), Y. Wang (Ann Arbor, United States), S. Murray (Ann Arbor, United States), J. Curtis (Ann Arbor, United States), R. Bowler (Denver, United States), C. Pistenmaa (Boston, United States), P. Nardelli (Boston, United States), R. San José Estépar (Boston, United States), R. San José Estépar (Boston, United States), K. Stringer (Ann Arbor, United States), G. Washko (Boston, United States), M. Han (Ann Arbor, United States). Differentiating metabolomic signatures of airway and pulmonary vascular abnormalities in COPD. 4252
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|